Cancer Metabolomics

Based on gene expression and DNA grouping, cancer genomics controls how the contrast between tumour cells and regular cells is portrayed. The goal of this inquiry is to better understand the fundamental hereditary characteristics of tumour progression, the alteration of the disease's genome, and the role of treatment in the cancer microenvironment. The study of the chemical traces a metabolite leaves behind during digestion is known as metabolomics. Examining the metabolite profile for sedative improvement in the event of the presence of tumour cells will be of the utmost importance. One of the many discoveries in disease metabolomics is the noninvasive validation of metabolic biomarkers from the bodily fluid of tumour patients.

    Related Conference of Cancer Metabolomics

    November 25-26, 2025

    21st World Summit on Blockchain Technology

    Amsterdam, Netherlands
    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    February 25-26, 2026

    15th International Conference on Herbal Medicine and Acupuncture

    Aix-en-Provence, France
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    October 19-20, 2026

    12th World Congress on Medicinal Plants and Marine Drugs

    Aix-en-Provence, France

    Cancer Metabolomics Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in